Unique market share and sales forecasts by product to 2012.
A comprehensive examination of four major oncology therapy areas.
Critical SWOT analyses of current and upcoming products.

This 325+ page market analysis provides a unique examination of four key oncology therapy areas:

Breast Cancer
Focusing on the changes in the gold standard, the impact of novel therapies on treatment and the new drugs in development. More>>

Non-Small Cell Lung Cancer
Focusing on the launch of novel therapies into the arena: are they dramatically changing the way NSCLC is treated? More>>

Colorectal Cancer
Focusing on the evolution of new treatment regimes, the development of new formulations and advances in cancer vaccines. More>>

Prostate Cancer
Focusing on current hormonal therapies, the treatment of HRPCA and improvements in screening. More>>
For each therapy area the report provides:
Comprehensive Overview

Patient statistics
Incidence;
Diagnosis and treatment rates.

Growth drivers
Risk factors (genetics, age, sex etc);
Stage of the disease;
Medical guidelines;
Unmet clinical need;
Screening programmes.

Current treatments
SWOT of drugs used and companies involved;
Summary of recent ASCO data (May 2005)
Highlight where and why there is still an unmet clinical need;
Sales forecasts by product 2004-2012.

Drugs in Phase II/III development
Focus on new classes of drugs and companies involved;
Sales forecasts by product (year of launch to 2012).

An overview of the value of the oncology market
Global sales;
Sales growth to 2012.

Overall conclusions
A summary of the areas of unmet clinical need and growth opportunities;
Who the major players are now and in the future.